Literature DB >> 9783530

Bioavailability of rifampicin, isoniazid and pyrazinamide from fixed-dose combination capsules.

Z Zwolska1, H Niemirowska-Mikulska, E Augustynowicz-Kopec, R Walkiewicz, H Stambrowska, A Safianowska, H Grubek-Jaworska.   

Abstract

SETTING: The absorption of rifampicin, isoniazid and pyrazinamide was tested after administration of each drug in free combinations and in a fixed-dose combination of the three drugs, known as Trifazid.
OBJECTIVE: To examine the relative bioavailability of rifampicin, isoniazid and pyrazinamide after oral administration of the drugs given alone in comparison to that of the same drugs after administration of Trifazid.
DESIGN: An open, randomized, cross-over study comprising 16 healthy volunteers.
RESULTS: The pattern of absorption, plasma concentrations and pharmacokinetic parameters were very similar after administration of the drugs in free and fixed combinations.
CONCLUSION: The triple combination of antituberculosis drugs could replace the separate drugs in the treatment of tuberculosis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9783530

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  4 in total

Review 1.  Fixed-dose combinations of drugs versus single-drug formulations for treating pulmonary tuberculosis.

Authors:  Carmen R Gallardo; David Rigau Comas; Angélica Valderrama Rodríguez; Marta Roqué i Figuls; Lucy Anne Parker; Joan Caylà; Xavier Bonfill Cosp
Journal:  Cochrane Database Syst Rev       Date:  2016-05-17

2.  Inhalable microparticles containing drug combinations to target alveolar macrophages for treatment of pulmonary tuberculosis.

Authors:  R Sharma; D Saxena; A K Dwivedi; A Misra
Journal:  Pharm Res       Date:  2001-10       Impact factor: 4.200

Review 3.  Fixed-dose combination drugs for tuberculosis: application in standardised treatment regimens.

Authors:  Bjørn Blomberg; Bernard Fourie
Journal:  Drugs       Date:  2003       Impact factor: 9.546

4.  Correlation of N-acetyltransferase 2 genotype with isoniazid acetylation in Polish tuberculosis patients.

Authors:  Anna Zabost; Sylwia Brzezińska; Monika Kozińska; Maria Błachnio; Jacek Jagodziński; Zofia Zwolska; Ewa Augustynowicz-Kopeć
Journal:  Biomed Res Int       Date:  2013-12-07       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.